Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1997 Jul 1;325(Pt 1):71–77. doi: 10.1042/bj3250071

Internalization and down-regulation of the prostacyclin receptor in human platelets.

S Giovanazzi 1, M R Accomazzo 1, O Letari 1, D Oliva 1, S Nicosia 1
PMCID: PMC1218530  PMID: 9224631

Abstract

The internalization of [3H]iloprost, a prostacyclin analogue, was studied in human platelets by binding studies. After incubation with [3H]iloprost at 37 degrees C, addition of unlabelled ligand at either 37 degrees C or 4 degrees C caused dissociation of 74% and 52% of the bound ligand respectively, suggesting that a portion had been internalized. The percentage of [3H]iloprost bound at equilibrium to the surface (evaluated by acid treatment) at either 37 degrees C or 4 degrees C was markedly different (80% versus 25%). Internalization was dependent on time and on the ligand nature and concentration. Energy-depleting agents (dinitrophenol and 2-deoxyglucose) completely inhibited internalization, whereas probenecid (inhibitor of organic anion transporters) did not affect it significantly. Subcellular fractionation indicated that, at 4 degrees C or in the absence of ligand, most of the receptor was present in membrane fractions (pellet at 27000 or 105000 g), whereas, when platelets were preincubated at 37 degrees C with iloprost, the receptor was found mainly in the cytosolic fraction. In platelets preincubated with iloprost at 4 degrees C, two classes of binding sites were present, whereas after preincubation at 37 degrees C only the lower-affinity sites were detected. After exposure to the agonist, iloprost-induced inhibition of platelet aggregation and activation of adenylate cyclase and cAMP production were significantly lower. Taken together, these data demonstrate that human platelets can internalize a high-affinity binding site for iloprost, presumably the prostacyclin receptor.

Full Text

The Full Text of this article is available as a PDF (443.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adie E. J., Mullaney I., McKenzie F. R., Milligan G. Concurrent down-regulation of IP prostanoid receptors and the alpha-subunit of the stimulatory guanine-nucleotide-binding protein (Gs) during prolonged exposure of neuroblastoma x glioma cells to prostanoid agonists. Quantification and functional implications. Biochem J. 1992 Jul 15;285(Pt 2):529–536. doi: 10.1042/bj2850529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alt U., Leigh P. J., Wilkins A. J., Morris P. K., MacDermot J. Desensitization of iloprost responsiveness in human platelets follows prolonged exposure to iloprost in vitro. Br J Clin Pharmacol. 1986 Jul;22(1):118–119. [PMC free article] [PubMed] [Google Scholar]
  3. BORN G. V. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962 Jun 9;194:927–929. doi: 10.1038/194927b0. [DOI] [PubMed] [Google Scholar]
  4. Best L. C., Martin T. J., Russell R. G., Preston F. E. Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets. Nature. 1977 Jun 30;267(5614):850–852. doi: 10.1038/267850a0. [DOI] [PubMed] [Google Scholar]
  5. Bito L. Z., Baroody R. A., Reitz M. E. Dependence of pulmonary prostaglandin metabolism on carrier-mediated transport processes. Am J Physiol. 1977 Apr;232(4):E383–E387. doi: 10.1152/ajpendo.1977.232.4.E382. [DOI] [PubMed] [Google Scholar]
  6. Blair I. A., Leigh P. J., MacDermot J. Desensitization of prostacyclin receptors in a neuronal hybrid cell line. Br J Pharmacol. 1982 Sep;77(1):121–127. doi: 10.1111/j.1476-5381.1982.tb09277.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Blomstedt J. W., Aronson P. S. pH gradient-stimulated transport of urate and p-aminohippurate in dog renal microvillus membrane vesicles. J Clin Invest. 1980 Apr;65(4):931–934. doi: 10.1172/JCI109748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Carpenter G., Cohen S. 125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts. J Cell Biol. 1976 Oct;71(1):159–171. doi: 10.1083/jcb.71.1.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. DeLean A., Munson P. J., Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol. 1978 Aug;235(2):E97–102. doi: 10.1152/ajpendo.1978.235.2.E97. [DOI] [PubMed] [Google Scholar]
  10. DiBenedetto F. E., Bito L. Z. Transport of prostaglandins and other eicosanoids by the choroid plexus: its characterization and physiological significance. J Neurochem. 1986 Jun;46(6):1725–1731. doi: 10.1111/j.1471-4159.1986.tb08490.x. [DOI] [PubMed] [Google Scholar]
  11. Forti G., Salerno R., Moneti G., Zoppi S., Fiorelli G., Marinoni T., Natali A., Costantini A., Serio M., Martini L. Three-month treatment with a long-acting gonadotropin-releasing hormone agonist of patients with benign prostatic hyperplasia: effects on tissue androgen concentration, 5 alpha-reductase activity and androgen receptor content. J Clin Endocrinol Metab. 1989 Feb;68(2):461–468. doi: 10.1210/jcem-68-2-461. [DOI] [PubMed] [Google Scholar]
  12. Gladhaug I. P., Christoffersen T. Amiloride inhibits constitutive internalization and increases the surface number of epidermal growth factor receptors in intact rat hepatocytes. J Cell Physiol. 1990 Apr;143(1):188–195. doi: 10.1002/jcp.1041430126. [DOI] [PubMed] [Google Scholar]
  13. Gladhaug I. P., Christoffersen T. Kinetics of epidermal growth factor binding and processing in isolated intact rat hepatocytes. Dynamic externalization of receptors during ligand internalization. Eur J Biochem. 1987 Apr 15;164(2):267–275. doi: 10.1111/j.1432-1033.1987.tb11054.x. [DOI] [PubMed] [Google Scholar]
  14. Gorman R. R., Bunting S., Miller O. V. Modulation of human platelet adenylate cyclase by prostacyclin (PGX). Prostaglandins. 1977 Mar;13(3):377–388. doi: 10.1016/0090-6980(77)90018-1. [DOI] [PubMed] [Google Scholar]
  15. Gorman R. R., Hopkins N. K. Agonist-specific desensitization of PGI2-stimulated cyclic AMP accumulation by PGE1 in human foreskin fibroblasts. Prostaglandins. 1980 Jan;19(1):2–16. doi: 10.1016/0090-6980(80)90148-3. [DOI] [PubMed] [Google Scholar]
  16. Haigler H. T., Maxfield F. R., Willingham M. C., Pastan I. Dansylcadaverine inhibits internalization of 125I-epidermal growth factor in BALB 3T3 cells. J Biol Chem. 1980 Feb 25;255(4):1239–1241. [PubMed] [Google Scholar]
  17. Hall J. M., Strange P. G. The use of a prostacyclin analogue, [3H]iloprost, for studying prostacyclin-binding sites on human platelets and neuronal hybrid cells. Biosci Rep. 1984 Nov;4(11):941–948. doi: 10.1007/BF01116892. [DOI] [PubMed] [Google Scholar]
  18. Hallam T. J., Rink T. J. Responses to adenosine diphosphate in human platelets loaded with the fluorescent calcium indicator quin2. J Physiol. 1985 Nov;368:131–146. doi: 10.1113/jphysiol.1985.sp015850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Homma H., Tokumura A., Hanahan D. J. Binding and internalization of platelet-activating factor 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine in washed rabbit platelets. J Biol Chem. 1987 Aug 5;262(22):10582–10587. [PubMed] [Google Scholar]
  20. Jaschonek K., Faul C., Schmidt H., Renn W. Desensitization of platelets to iloprost. Loss of specific binding sites and heterologous desensitization of adenylate cyclase. Eur J Pharmacol. 1988 Mar 1;147(2):187–196. doi: 10.1016/0014-2999(88)90777-7. [DOI] [PubMed] [Google Scholar]
  21. Kelly E., Keen M., Nobbs P., MacDermot J. Segregation of discrete GS alpha-mediated responses that accompany homologous or heterologous desensitization in two related somatic hybrids. Br J Pharmacol. 1990 Feb;99(2):309–316. doi: 10.1111/j.1476-5381.1990.tb14700.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Laduron P. M. From receptor internalization to nuclear translocation. New targets for long-term pharmacology. Biochem Pharmacol. 1994 Jan 13;47(1):3–13. doi: 10.1016/0006-2952(94)90431-6. [DOI] [PubMed] [Google Scholar]
  23. Lamb J. E., Ray F., Ward J. H., Kushner J. P., Kaplan J. Internalization and subcellular localization of transferrin and transferrin receptors in HeLa cells. J Biol Chem. 1983 Jul 25;258(14):8751–8758. [PubMed] [Google Scholar]
  24. Leigh P. J., MacDermot J. Desensitization of prostacyclin responsiveness in a neuronal hybrid cell line: selective loss of high affinity receptors. Br J Pharmacol. 1985 May;85(1):237–247. doi: 10.1111/j.1476-5381.1985.tb08852.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Litwack G., Filler R., Rosenfield S., Lichtash N. Macromolecular binding of (5,6-3H) prostaglandin E1 in liver cytosol in vitro. Biochem Biophys Res Commun. 1973 Dec 10;55(3):977–984. doi: 10.1016/0006-291x(73)91238-2. [DOI] [PubMed] [Google Scholar]
  26. Lombroso M., Nicosia S., Paoletti R., Whittle B. J., Moncada S., Vane J. R. The use of stable prostaglandins to investigate prostacyclin (PGI2)-binding sites and PGI2-sensitive adenylate cyclase in human platelet membranes. Prostaglandins. 1984 Feb;27(2):321–333. doi: 10.1016/0090-6980(84)90083-2. [DOI] [PubMed] [Google Scholar]
  27. Marcus A. J., Zucker-Franklin D., Safier L. B., Ullman H. L. Studies on human platelet granules and membranes. J Clin Invest. 1966 Jan;45(1):14–28. doi: 10.1172/JCI105318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Miller O. V., Gorman R. R. Evidence for distinct prostaglandin I2 and D2 receptors in human platelets. J Pharmacol Exp Ther. 1979 Jul;210(1):134–140. [PubMed] [Google Scholar]
  29. Misselwitz F., Leytin V. L., Repin V. S. Effect of metabolic inhibitors on platelet attachment, spreading and aggregation on collagen-coated surfaces. Thromb Res. 1987 Apr 15;46(2):233–240. doi: 10.1016/0049-3848(87)90285-4. [DOI] [PubMed] [Google Scholar]
  30. Modesti P. A., Fortini A., Poggesi L., Boddi M., Abbate R., Gensini G. F. Acute reversible reduction of PGI2 platelet receptors after iloprost infusion in man. Thromb Res. 1987 Dec 15;48(6):663–669. doi: 10.1016/0049-3848(87)90432-4. [DOI] [PubMed] [Google Scholar]
  31. Moncada S. Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclin. Br J Pharmacol. 1982 May;76(1):3–31. doi: 10.1111/j.1476-5381.1982.tb09186.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Munson P. J., Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem. 1980 Sep 1;107(1):220–239. doi: 10.1016/0003-2697(80)90515-1. [DOI] [PubMed] [Google Scholar]
  33. Murray R., FitzGerald G. A. Regulation of thromboxane receptor activation in human platelets. Proc Natl Acad Sci U S A. 1989 Jan;86(1):124–128. doi: 10.1073/pnas.86.1.124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Okwu A. K., Ullian M. E., Halushka P. V. Homologous desensitization of human platelet thromboxane A2/prostaglandin H2 receptors. J Pharmacol Exp Ther. 1992 Jul;262(1):238–245. [PubMed] [Google Scholar]
  35. Oliva D. W., Maderna P., Accomazzo M. R., Nicosia S., Tremoli E. Iloprost binding and inhibition of aggregation in platelet rich plasma. Differences between normal and type IIa hypercholesterolemic subjects. Biochem Pharmacol. 1989 Jan 1;38(1):39–45. doi: 10.1016/0006-2952(89)90146-9. [DOI] [PubMed] [Google Scholar]
  36. Rovati G. E. Rational experimental design and data analysis for ligand binding studies: tricks, tips and pitfalls. Pharmacol Res. 1993 Dec;28(4):277–299. doi: 10.1006/phrs.1993.1131. [DOI] [PubMed] [Google Scholar]
  37. Salomon Y., Londos C., Rodbell M. A highly sensitive adenylate cyclase assay. Anal Biochem. 1974 Apr;58(2):541–548. doi: 10.1016/0003-2697(74)90222-x. [DOI] [PubMed] [Google Scholar]
  38. Sinzinger H., Silberbauer K., Horsch A. K., Gall A. Decreased sensitivity of human platelets to PGI2 during long-term intraarterial prostacyclin infusion in patients with peripheral vascular disease--a rebound phenomenon? Prostaglandins. 1981 Jan;21(1):49–51. doi: 10.1016/0090-6980(81)90195-7. [DOI] [PubMed] [Google Scholar]
  39. Tateson J. E., Moncada S., Vane J. R. Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets. Prostaglandins. 1977 Mar;13(3):389–397. doi: 10.1016/0090-6980(77)90019-3. [DOI] [PubMed] [Google Scholar]
  40. Tremoli E., Maderna P., Sirtori M., Sirtori C. R. Platelet aggreation malondialdehyde formation in type IIA hypercholesterolemic patients. Haemostasis. 1979;8(1):47–53. doi: 10.1159/000214290. [DOI] [PubMed] [Google Scholar]
  41. Watanabe N., Kuriyama H., Sone H., Neda H., Yamauchi N., Maeda M., Niitsu Y. Continuous internalization of tumor necrosis factor receptors in a human myosarcoma cell line. J Biol Chem. 1988 Jul 25;263(21):10262–10266. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES